Skip to main content

InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Integra Pharma Partners with Pharmaceutical Co. to Help Network Members Succeed

TRxADE Health (NASDAQ: MEDS), through its wholly owned pharmaceutical wholesale business, Integra Pharma Solutions LLC, has inked a distribution agreement with GALT Pharmaceuticals LLC. Integra currently distributes generic and brand medications directly in 34 states through its warehouse; the new partnership adds single-source and multisource products directly from GALT Pharmaceuticals to its offering, supporting Integra’s mission of supporting independent pharmacies and helping its members access top medication products. GALT Pharmaceuticals has created a unique pharmaceutical franchise concept, called “phranchise,” that moves product representation away from corporate headquarters into local communities. GALT phranchises provide education to local healthcare providers while the company manages functions such as drug research, regulatory approval, compliance and supply chain. “We are pleased to partner with an innovative pharmaceutical company like GALT Pharmaceuticals,” said TRxADE Health chief clinical and compliance officer Dr. Shafaat Pirani, PharmD, BCGP, in the press release. “Many of the products manufactured by GALT are single-source items, thereby facilitating preferred access channels to our independent network of pharmacies. . . . This partnership is aligned with our core competency at TRxADE Health, putting our independent pharmacies in a position to succeed by providing them with access to novel products and transparent pricing so that they can better serve the patients entrusting them with their care.”

To view the full press release, visit

About TRxADE Health Inc

TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 13,475 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit and

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.